Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01491945 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System

A NA study of Abdominal Aortic Aneurysm, sponsored by Endologix.

Completed
Registry status
NA
Development phase
76
Enrollment target
20
Study locations

NCT01491945: Completed NA study of Abdominal Aortic Aneurysm, sponsored by Endologix.

NCT01491945 is a NA study of Abdominal Aortic Aneurysm that has completed, run by Endologix. The registered enrollment target is 76 participants, below the 449-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (83% lower). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01491945, a NA study of Abdominal Aortic Aneurysm, has completed, sponsored by Endologix.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this trial is to determine if the Ventana Fenestrated Stent Graft System is safe and effective for the endovascular repair of juxtarenal or pararenal aortic aneurysms.

Primary Outcome

Major Adverse Events = all cause death; bowel ischemia; myocardial infarction; paraplegia; renal failure; respiratory complications of stroke; blood loss \>1000cc

Conditions Studied

Interventions

  • DEVICE Ventana Fenestrated Stent Graft System

Study Locations (20)

California

  • John Muir Medical Center Concord, CA - Concord
  • UCLA Medical Center - Los Angeles

Massachusetts

  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia
  • UPMC - Pittsburgh

Alabama

  • University of Alabama at Birmingham - Birmingham

Arizona

  • Arizona Heart Institute - Phoenix

Florida

  • VA Gainesville - Gainesville

Georgia

  • Emory University - Atlanta

Indiana

  • Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2013-03-03
Est. Completion 2018-08-01
Phase NA
Endologix

17 total trials

What the finished NCT01491945 record still lists

NCT01491945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 449-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Ventana Fenestrated Stent Graft System is the first listed.

NCT01491945 names 20 study sites across 17 states, led by California, Massachusetts, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01491945 about?

NCT01491945 is a clinical study titled "Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System". The purpose of this trial is to determine if the Ventana Fenestrated Stent Graft System is safe and effective for the endovascular repair of juxtarenal or pararenal aortic aneurysms.

What is the current status of trial NCT01491945?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2013-03-03. Estimated completion is 2018-08-01.

What conditions does trial NCT01491945 study?

This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.

What interventions are being tested in trial NCT01491945?

The interventions under investigation include: Ventana Fenestrated Stent Graft System (DEVICE).

Who is sponsoring clinical trial NCT01491945?

This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01491945 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01491945's enrollment target sits among peer trials

76 11th of 16 higher than 6 of 16 other Abdominal Aortic Aneurysm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Abdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01491945, the US trial registry maintained by the National Library of Medicine. NCT01491945 (small enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.